Immediate Impact

1 by Nobel laureates 1 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Standout
1 intermediate paper

Works of Kenichiro Seki being referenced

Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake
2017
Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis
2015

Author Peers

Author Last Decade Papers Cites
Kenichiro Seki 297 129 140 209 184 36 702
Masanori Furukawa 294 183 145 208 100 39 622
Tetsuro Sohda 294 243 128 200 121 65 771
Gregory Kouraklis 173 164 218 201 180 43 785
Hang Zhou 239 50 125 170 144 49 734
Roberto Caporale 254 174 124 268 163 29 847
Stephan Buch 219 82 169 163 122 31 623
Hisaaki Miyoshi 186 126 173 397 246 41 780
Matteo Montani 311 256 235 117 94 44 811
Yingying Li 152 178 147 86 167 52 582
Jie Zhang 164 66 80 171 77 57 708

All Works

Loading papers...

Rankless by CCL
2026